PB1763: A PHASE 1/2 STUDY TO EVALUATE PONATINIB WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH RELAPSED/RESISTANT/INTOLERANT PHILADELPHIA CHROMOSOME–POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR WITH T315I MUTATION

Bibliographic Details
Main Authors:	L. Gore, M. Loh, C.-H. Pui, Y. Matloub, M. J. Hanley, J. Du, M. Hennessy, M. Granier, A. Biondi, L. Silverman
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000849908.11106.d2

Internet